|
|
|
Monday, November 15th |
|
07.00-16.30 |
Registration desk |
|
08.30-08.45 |
Welcome address and introduction
Nils Wahlgren, Stockholm, and Didier Leys, Lille
|
|
08.45-10.15 |
Session: Carotid endarterectomy vs angioplasty
Chairs: Jean-Louis Mas, Paris / Secretary: Konstantinos Kostulas, Stockholm
|
|
| 08.45-09.05 |
Carotid Stenting is as safe and as effective as carotid surgery in patients at risk for stroke - results from the Carotid Revascularization Endarterectomy vs Stenting Trial (CREST)
Michael D Hill, Calgary |
|
| 09.05-09.25 |
Carotid endarterectomy should remain the treatment of choice for patients suitable for surgery, except in younger patients: results from the Carotid Stenting Trialists Collaboration
Leo Bonati, London |
|
| 09.25-09.45 |
What is the overall impression of carotid endarterectomy vs stenting trials?
Peter Rothwell, Oxford |
|
| 09.45-09.55 |
Presentation of draft statement
Jean-Louis Mas/ Konstantinos Kostulas |
|
09.55-10.15 |
Consensus discussion and statement
Chaired by Jean-Louis Mas, Paris
|
|
10.15-10.45 |
Special lecture: Stroke management - are we successful enough?
Speaker: Takenori Yamaguchi, Osaka
|
|
| 10.45-11.15 |
Coffee Break |
|
11.15-12.15 |
Session: Cerebral artery dissection
Chair: Jacques De Keyser, Brussels /Secretary: Christina Sjöstrand, Stockholm
|
|
| 11.15-11.35 |
Management of extracranial artery dissections
Marie-Germaine Bousser, Paris |
|
| 11.35-11.50 |
Management of intracranial artery dissections
Gert-Jan Luijckx, Groningen |
|
11.50-12.00 |
Presentation of draft statement
Jacques De Keyser/ Christina Sjöstrand, Stockholm |
|
12.00-12.15 |
Consensus discussion and statement
Chaired by Jacques De Keyser, Brussels |
|
12.15-13.15 |
Lunch and poster exhibition |
|
13.15-14.25 |
Session: Subarachnoid haemorrhage and aneurysms - new guidelines
Chair: Thorsten Steiner, Heidelberg, and Gabriel Rinkel, Utrecht./Secretary: Michael Mazya, Stockholm |
|
| 13.15-13.30 |
Primary prevention: Intervention for unruptured aneurysms and arteriovenous malformations
Christian Stapf, Paris |
|
| 13.30-13.45 |
Secondary prevention: Neurosurgery for ruptured aneurysms and arteriovenous malformations
Hartmut Vatter, Frankfurt |
|
13.45-14.00 |
Secondary prevention: Endovascular treatment for ruptured aneurysms and arteriovenous malformations
Tommy Andersson, Stockholm
|
|
14.00-14.10 |
Presentation of draft statement, including a short statement on the current status of guidelines on SAH by Gabriel Rinkel, Utrecht
Thorsten Steiner, Heidelberg/ Michael Mazya, Stockholm |
|
14.10-14.25 |
Consensus discussion and statement
Chaired by Thorsten Steiner, Heidelberg |
|
14.25-14.55 |
Coffee break |
|
14.55-16.25 |
Session: Prevention of stroke in atrial fibrillation
Chair: Gary Ford, Newcastle and Bo Norrving, Lund/Secretary: Mia von Euler, Stockholm |
|
| 14.55-15.15 |
Dabigatran is superior to Warfarin in primary and secondary prevention of stroke in patients with atrial fibrillation - overall results of the RE-LY study
Christoph Diener, Essen |
|
| 15.15-15.35 |
Warfarin may still be the better alternative
Didier Leys, Lille |
|
| 15.35-15.50 |
Reserved time for last minute presentation
TBA |
|
| 15.50-16:00 |
Presentation of draft statement
Gary Ford, Newcastle/ Mia von Euler, Stockholm |
|
16.00-16.15 |
Consensus discussion and statement
Chaired by Gary Ford, Newcastle |
|
16.15-16.25 |
Summary and closing of the first day of the meeting, original programme
Nils Wahlgren, Stockholm |
|
| 16.25-17.00 |
Karolinska Stroke Award Ceremony
Ceremony in the presence of the President of Karolinska Institutet Harriet Wallberg-Henriksson |
|
| |
All participants are welcome to the following satellite session: |
|
17.05-18.00 |
SITS investigators' open session
Chair: Niaz Ahmed, Stockholm
Open for all meeting participants |
|
| 17.05-17.15 |
SITS as a global tool for stroke quality development and research - the new database
Nils Wahlgren, Stockholm |
|
| 17.15-17.30 |
Helsinki,.world leading stroke centre in SITS: The pathway to minimal treatment delays
Lauri Soinne, Helsinki |
|
| 17.30-17.45 |
Czech Republic, successful nation in SITS: Finding the optimal organisation for thrombolysis
Robert Mikulik, Brno |
|
| 17.45-18.00 |
UK, successful nation in SITS
Gary Ford, Newcastle |
|
| 19:15-20:15 |
Welcome cocktail in the "Upstairs bar" |
|
20:15 |
Gala Dinner |
|
|
|
|
Tuesday, November 16th |
|
08.30-08.35 |
Introduction to day 2 |
|
08.35-10.20 |
Session: Reperfusion therapy - intravenous thrombolysis
Chair: Markku Kaste, Helsinki/ Secretary: Nikolaos Kostulas, Stockholm
|
|
08.35-08.55 |
Extension of the time window for intravenous thrombolysis to 4.5 h, update on efficacy and safety based on pooled RCT and SITS data
Danilo Toni, Rome |
|
| 08.55-09.15 |
Extension of thrombolysis beyond a time window of 4.5 h: the role of multimodal imaging
Jan Sobesky, Berlin |
|
| 09.15-09.35 |
Can thrombolysis be extended to the very elderly, to all baseline severity grades and patients with diabetes and previous stroke - data from SITS and VISTA collaborations
Kennedy R Lees, Glasgow |
|
| 09.35-09.55 |
Intracerebral haemorrhage after thrombolysis - prediction and outcome
Michael Mazya, Stockholm |
|
| 09.55-10.05 |
Presentation of draft statement
Markku Kaste, Helsinki/ Nikolaos Kostulas, Stockholm |
|
10.05-10.20 |
Consensus discussion and statement
Chaired by Markuu Kaste, Helsinki |
|
10.20-10.50 |
Coffee break |
|
10.50-11.10 |
Special lecture: Intravenous thrombolysis - a dynamic report from SITS 2003-2010
Speaker: Nils Wahlgren, Stockholm |
|
11.10-12.10 |
Session: Reperfusion therapy - thrombectomy
Chair: Peter Ringleb, Heidelberg/.Secretary: Magnus Thorén, Stockholm |
|
| 11.10-11.30 |
Thrombectomy is evidence.based treatment - state of the art
Natan Bornstein, Tel Aviv |
|
| 11.30-11.45 |
Thrombectomy is not evidence-based treatment
Peter Schellinger, Minden |
|
| 11.45-11.55 |
Presentation of draft statement
Peter Ringleb, Heidelberg/ Magnus Thorén, Stockholm |
|
| 11.55-12.10 |
Consensus discussion and statement
Chaired by Peter Ringleb, Heidelberg |
|
12.10-13.05 |
Lunch and poster exhibition
Clinical trials presentation will occur in the auditorium during the lunch break with start 12:40
12:40-12:50: IST-3, an update (Veronica Murray Stockholm on behalf of the IST-3 collaborative group)
|
|
13.05-13.30 |
Special lecture: Implementation of stroke programmes and guidelines in clinical practice - lessons learned from stroke registers
Speaker: Bo Norrving, Lund |
|
13.30-14.35 |
Session: Reperfusion therapy: Sonothrombolysis
Chair: David Russell, Oslo / Secretary: Tiago Moreira, Stockholm, |
|
13.30-13.50 |
Sonothrombolysis: current evidence and future perspectives
Robert Mikulik, Brno |
|
| 13.50-14.10 |
Sonothrombolysis, what can we hope for?
Stephen Meairs, Mannheim |
|
| 14.10-14.20 |
Presentation of draft statement
David Russell, Oslo, Tiago Moreira, Stockholm |
|
14.20-14.35 |
Consensus discussion and statement
David Russell, Oslo |
|
14.35-15.05 |
Coffee break |
|
15.10-17.05 |
Session: Management of intracerebral haemorrhage
Chair Thorsten Steiner, Heidelberg and Gabriel Rinkel, Utrecht /Secretary: Michael Mazya, Stockholm |
|
15.10-15.25 |
Overview of intracerebral haemorrhage
Thorsten Steiner, Heidelberg |
|
| 15.25-15.40 |
Imaging in ICH
Charlotte Cordonnier, Lille
|
|
15.40-15.55 |
Status of surgical treatment of intracerebral haemorrhage
Dan Hanley, Baltimore |
|
16.55-16.10 |
Status of pharmacological haemostasis in intracerebral haemorrhage
Karsten Overgaard, Copenhagen |
|
| 16.10-16.25 |
Blood pressure management in intracerebral haemorrhage
Christian Stapf, Paris |
|
| 16.25-16.40 |
Neuroprotection in intracerebral haemorrhage
Jesper Petersson, Malmö |
|
| 16.40-16.50 |
Presentation of draft statement
Thorsten Steiner, Heidelberg/ Michael Mazya, Stockholm |
|
| 16.50-17.05 |
Consensus discussion and statement
Chaired by Thorsten Steiner, Heidelberg |
|
17.05-17.15 |
Summary and closing of the meeting
Nils Wahlgren, Stockholm |
|
